Prostate-specific antigen screening can be beneficial to younger and at-risk men

被引：1
|
作者：
Roobol, Monique J. [1 ]
Bangma, Chris H. [1 ]
Loeb, Stacy [2 ]
机构：
[1] Erasmus Univ, Dept Urol, Med Ctr, NL-3000 DR Rotterdam, Netherlands
[2] NYU, Dept Urol, New York, NY USA
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2013年 / 185卷 / 01期
关键词：
RANDOMIZED CONTROLLED-TRIAL; SERVICES TASK-FORCE; FOLLOW-UP; RADICAL PROSTATECTOMY; CANCER MORTALITY; COMPLICATIONS; PROGRAM; TIME; LIFE;
D O I：
10.1503/cmaj.111962
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：47 / 51
页数：5
相关论文
共 50 条
  • [1] Prostate-Specific Antigen-Based Risk Assessment in Younger Men
    Strope, Seth A.
    Andriole, Gerald L.
    EUROPEAN UROLOGY, 2012, 61 (01) : 8 - 9
  • [2] PROSTATE-CANCER SCREENING IN YOUNGER MEN - PROSTATE-SPECIFIC ANTIGEN AND PUBLIC AWARENESS
    MOON, TD
    CLEJAN, S
    UROLOGY, 1991, 38 (03) : 216 - 219
  • [3] Prostate-specific antigen screening in elderly men
    Lu-Yao, G
    Stukel, TA
    Yao, SL
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (23) : 1792 - 1797
  • [4] Can prostate-specific antigen and prostate-specific antigen velocity be used for prostate cancer screening in men older than 70 years?
    Mouraviev, Vladimir
    Broadwater, Gloria
    Sun, Leon
    Mayes, Janice M.
    Moul, Judd W.
    Polascik, Thomas J.
    UROLOGY, 2008, 71 (06) : 1020 - 1023
  • [5] Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men
    Turner, Aubrey R.
    Lane, Brian R.
    Rogers, Dan
    Lipkus, Isaac
    Weaver, Kathryn
    Danhauer, Suzanne C.
    Zhang, Zheng
    Hsu, Fang-Chi
    Noyes, Sabrina L.
    Adams, Tamara
    Toriello, Helga
    Monroe, Thomas
    McKanna, Trudy
    Young, Tracey
    Rodarmer, Ryan
    Kahnoski, Richard J.
    Tourojman, Mouafak
    Kader, A. Karim
    Zheng, S. Lilly
    Baer, William
    Xu, Jianfeng
    CANCER, 2016, 122 (22) : 3564 - 3575
  • [6] Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old
    Loeb, S
    Roehl, KA
    Antenor, JAV
    Catalona, WJ
    Suarez, BK
    Nadler, RB
    UROLOGY, 2006, 67 (02) : 316 - 320
  • [7] Upcoming evidences on prostate-specific antigen-based screening for men at risk of prostate cancer
    Boscolo-Berto, Rafael
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (09) : 711 - 711
  • [8] Investigating the racial gap in prostate cancer screening with prostate-specific antigen among younger men from 2012 to 2020
    Qian, Zhiyu
    Al Khatib, Khalid
    Chen, Xi
    Belani, Sanvi
    Labban, Muhieddine
    Lipsitz, Stuart
    Cole, Alexander P.
    Iyer, Hari S.
    Trinh, Quoc-Dien
    JNCI CANCER SPECTRUM, 2023, 7 (02)
  • [9] Prostate-specific antigen screening
    Biehn, John
    CANADIAN FAMILY PHYSICIAN, 2011, 57 (09) : 993 - 993
  • [10] Should prostate-specific antigen screening be offered to asymptomatic men?
    van Vugt, Heidi A.
    Bangma, Chris H.
    Roobol, Monique J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (07) : 1043 - 1053
12345